[Corrections] Correction to Lancet Oncol 2026; 27: 90–102

Sun J-M, Chao Y, Kim S-B, et al. First-line tiragolumab plus atezolizumab and chemotherapy in patients with previously untreated, locally advanced unresectable or metastatic oesophageal cancer (MORPHEUS-EC): a randomised, open-label, phase 1b/2 trial. Lancet Oncol 2026; 27: 90–102—This Article was published with the incorrect appendix file. The file has been corrected as of Feb 2, 2026.